Fifth disease - Senkyèm Maladi
☆ AI Dermatology — Free Service
Nan rezilta Stiftung Warentest 2022 ki soti nan Almay, satisfaksyon konsomatè yo ak ModelDerm te sèlman yon ti kras pi ba pase ak konsiltasyon telemedsin peye.
Nan rezilta Stiftung Warentest 2022 ki soti nan Almay, satisfaksyon konsomatè yo ak ModelDerm te sèlman yon ti kras pi ba pase ak konsiltasyon telemedsin peye.
Timoun 16 mwa ki gen Senkyèm Maladi (Fifth disease) — Tou de machwè yo vin wouj, tankou si yo te soufle, epi gratèl makulopapular parèt sou kò a.
Eritèm sou tou de machwè.
relevance score : -100.0%
ReferencesFifth disease, ke yo rele tou erythema infectiosum, se yon enfeksyon viral ki koze pa parvoviris imen B19. Li pi souvan rive timoun yo, tipikman afekte timoun ki gen ant 4 a 14 an. Sentòm yo souvan kòmanse ak ti lafyèv, maltèt, doulè gòj, ak santiman ki sanble ak grip. Timoun yo ka devlope yon gratèl wouj sou figi a ki sanble ak slapped cheeks, ansanm ak gratèl ki parèt sou kò a, bra, ak janm. Nan granmoun, doulè jwenti se yon plent komen ki ka parèt kèk semèn apre premye enfeksyon an. Anplis, anviwon 20 a 30 % adilt ki enfekte ak parvovirus B19 pa montre okenn sentòm.
Fifth disease (erythema infectiosum) is a viral infection caused by human parvovirus B19. It is more common in children than adults and usually affects children ages 4 to 14. The disease often starts with mild fever, headache, sore throat, and other flu-like symptoms. Children can also develop a bright red rash on the face that looks like “slapped cheeks”, along with a lacy or bumpy rash on the body, arms, and legs. In adults, joint aches are a common symptom. Rash and joint symptoms may develop several weeks after infection. About 20 to 30% of adults who are infected with parvovirus B19 will not have symptoms.
Fifth disease (erythema infectiosum) is a viral infection caused by human parvovirus B19. It is more common in children than adults and usually affects children ages 4 to 14. The disease often starts with mild fever, headache, sore throat, and other flu-like symptoms. Children can also develop a bright red rash on the face that looks like “slapped cheeks”, along with a lacy or bumpy rash on the body, arms, and legs. In adults, joint aches are a common symptom. Rash and joint symptoms may develop several weeks after infection. About 20 to 30% of adults who are infected with parvovirus B19 will not have symptoms.
Risk pou transmisyon parvovirus B19 soti nan manman bay tibebe a se anviwon 33 %, epi apeprè 3 % nan fanm ki enfekte yo ka genyen konplikasyon pou tibebe yo. Lè manman an vin enfekte anvan 20 semèn gwosès la, chans pou konplikasyon tankou pwoblèm san ak akimilasyon likid nan kò tibebe a ogmante. Pou kòmanse jere maladi sa a, nou ta dwe verifye si pasyan an te janm ekspoze a parvovirus atravè tès pou antikò (IgM). Si tès la pa montre okenn ekspoze sot pase, men li endike yon enfeksyon ki sot pase, pasyan an bezwen siveyans sere pandan gwosès la, ki gen ladan analiz ultrason regilye pou tcheke nenpòt pwoblèm sante tibebe a.
The rate of vertical transmission during maternal parvovirus B19 infection is estimated at 33%, with fetal complications occurring in 3% of infected women. Fetal complications comprising hemolysis, anemia, and nonimmune hydrops fetalis and fetal loss are more frequent when maternal infection occurs before 20 weeks of gestation. The first step in the management of this patient would be to obtain immunoglobulin (Ig) M and IgG titres against parvovirus to evaluate if the patient has had previous immunity against the disease. If results are negative for IgG but positive for IgM (ie, primary infection), this patient would need close obstetrical monitoring for the following weeks, including serial ultrasounds to rule out fetal anemia and hydrops fetalis.
The rate of vertical transmission during maternal parvovirus B19 infection is estimated at 33%, with fetal complications occurring in 3% of infected women. Fetal complications comprising hemolysis, anemia, and nonimmune hydrops fetalis and fetal loss are more frequent when maternal infection occurs before 20 weeks of gestation. The first step in the management of this patient would be to obtain immunoglobulin (Ig) M and IgG titres against parvovirus to evaluate if the patient has had previous immunity against the disease. If results are negative for IgG but positive for IgM (ie, primary infection), this patient would need close obstetrical monitoring for the following weeks, including serial ultrasounds to rule out fetal anemia and hydrops fetalis.
Li kòmanse ak yon lafyèv ki ba, maltèt, gratèl, ak sentòm tankou frèt, nen k ap koule oswa bouch. Apre kèk jou, gratèl la parèt. Gratèl wouj ki klere pi souvan parèt sou figi a, patikilyèman sou machwè yo (kidonk non “maladi souflèt souflèt”). Anplis de machwè wouj, timoun yo souvan devlope gratèl wouj ki sanble dantèl sou rès kò a, espesyalman sou anwo bra, tò, ak janm, ki se kote ki pi komen.
Maladi a anjeneral pa twò grav, men pou fanm ansent, enfeksyon nan premye trimès la lye ak idrops fetalis, ki ka lakòz foskouch espontane.
○ Tretman
Pa gen okenn tretman espesifik ki nesesè, paske li anjeneral amelyore sou tan.